Terms: = Kidney tumors AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Clinical Outcome
2 results:
1. A tightly controlled src-YAP signaling axis determines therapeutic response to dasatinib in renal cell carcinoma.
Sun J; Wang X; Tang B; Liu H; Zhang M; Wang Y; Ping F; Ding J; Shen A; Geng M
Theranostics; 2018; 8(12):3256-3267. PubMed ID: 29930727
[TBL] [Abstract] [Full Text] [Related]
2. High Throughput Kinomic Profiling of Human Clear Cell Renal Cell Carcinoma Identifies Kinase Activity Dependent Molecular Subtypes.
Anderson JC; Willey CD; Mehta A; Welaya K; Chen D; Duarte CW; Ghatalia P; Arafat W; Madan A; Sudarshan S; Naik G; Grizzle WE; Choueiri TK; Sonpavde G
PLoS One; 2015; 10(9):e0139267. PubMed ID: 26406598
[TBL] [Abstract] [Full Text] [Related]
